Skip to main content
. 2018 Oct 3;18:948. doi: 10.1186/s12885-018-4847-y

Table 1.

Genotype distribution of the lnc-LAMC2–1:1 rs2147578 C > G polymorphism and neuroblastoma susceptibility

Genotype Case Control P a Crude OR
(95% CI)
P Adjusted OR
(95% CI) b
P b
Guangdong province (HWE = 0.279)
 CC 88 (32.00) 195 (36.79) 1.00 1.00
 CG 130 (47.27) 243 (45.85) 1.19 (0.85–1.65) 0.312 1.18 (0.85–1.64) 0.332
 GG 57 (20.73) 92 (17.36) 1.37 (0.91–2.08) 0.135 1.38 (0.91–2.10) 0.127
 Additive 0.305 1.17 (0.96–1.44) 0.124 1.18 (0.96–1.44) 0.120
 Dominant 187 (68.00) 335 (63.21) 0.177 1.24 (0.91–1.68) 0.177 1.23 (0.91–1.68) 0.183
 Recessive 218 (79.27) 438 (82.64) 0.243 1.25 (0.86–1.80) 0.244 1.26 (0.87–1.82) 0.223
Henan province (HWE = 0.386)
 CC 29 (24.58) 99 (35.36) 1.00 1.00
 CG 67 (56.78) 129 (46.07) 1.77 (1.07–2.95) 0.027 1.73 (1.03–2.89) 0.037
 GG 22 (18.64) 52 (18.57) 1.44 (0.76–2.76) 0.266 1.42 (0.74–2.74) 0.291
 Additive 0.085 1.25 (0.92–1.70) 0.158 1.23 (0.90–1.69) 0.186
 Dominant 89 (75.42) 181 (64.64) 0.036 1.68 (1.03–2.73) 0.037 1.64 (1.004–2.68) 0.048
 Recessive 96 (81.36) 228 (81.43) 0.986 1.01 (0.58–1.75) 0.986 1.00 (0.57–1.74) 1.000
Combined (HWE = 0.164)
 CC 117 (29.77) 294 (36.30) 1.00 1.00
 CG 197 (50.13) 372 (45.93) 1.33 (1.01–1.75) 0.042 1.33 (1.01–1.75) 0.045
 GG 79 (20.10) 144 (17.78) 1.38 (0.97–1.95) 0.071 1.38 (0.97–1.95) 0.074
 Additive 0.080 1.19 (1.01–1.41) 0.043 1.19 (1.004–1.41) 0.045
 Dominant 276 (70.23) 516 (63.70) 0.025 1.34 (1.04–1.74) 0.025 1.34 (1.03–1.74) 0.028
 Recessive 314 (79.90) 666 (82.22) 0.331 1.16 (0.86–1.58) 0.331 1.16 (0.86–1.58) 0.333

a χ2 test for genotype distribution in neuroblastoma cases and cancer-free controls

b Adjusted for age and gender

OR odds ratio, CI confidence interval

The values were in bold if the 95% CI excluded 1, or P<0.05